ID: ALA5271554

Max Phase: Preclinical

Molecular Formula: C21H20O4

Molecular Weight: 336.39

Associated Items:

Representations

Canonical SMILES:  CC(=O)CC(c1ccccc1)c1c(O)c2ccc(C)c(C)c2oc1=O

Standard InChI:  InChI=1S/C21H20O4/c1-12-9-10-16-19(23)18(21(24)25-20(16)14(12)3)17(11-13(2)22)15-7-5-4-6-8-15/h4-10,17,23H,11H2,1-3H3

Standard InChI Key:  GRNWABPJIBXECJ-UHFFFAOYSA-N

Associated Targets(non-human)

Human immunodeficiency virus type 1 protease 9113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 336.39Molecular Weight (Monoisotopic): 336.1362AlogP: 4.23#Rotatable Bonds: 4
Polar Surface Area: 67.51Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.79CX Basic pKa: CX LogP: 3.77CX LogD: 2.18
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.72Np Likeness Score: 0.24

References

1. Hassan MZ, Osman H, Ali MA, Ahsan MJ..  (2016)  Therapeutic potential of coumarins as antiviral agents.,  123  [PMID:27484512] [10.1016/j.ejmech.2016.07.056]

Source